Atomoxetine for the treatment of pediatric nocturnal enuresis.
Current treatments for pediatric nocturnal enuresis rely upon the use of behavioral interventions, such as enuresis alarms, and pharmacological interventions, such as antidiuretic hormone analogs, tricyclic antidepressants, and anticholinergics. However, a considerable number of patients do not respond fully to any of these interventions, in spite of optimal behavioral management and medication dosing. This report describes 4 children with attention deficit hyperactivity disorder (ADHD) comorbid with nocturnal enuresis. Each child was treated with atomoxetine for ADHD and experienced serendipitous resolution of enuresis.
Shatkin
Jess P
JP
Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. shatkinjp@upmc.edu
D000293:Adolescent; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy / Q000523:psychology; D002648:Child; D004775:Enuresis / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D008297:Male; D011437:Propylamines / Q000627:therapeutic use*
D011437:Propylamines; D000069445:Atomoxetine Hydrochloride